Biotech
OncoImmune, Inc.
1
Articles
Deal Party
Top Role
Apr 11, 2026
First Mention
Apr 11, 2026
Last Mention
1.55
Relevance Score
Coverage Timeline
April 2026
Apr 11, 2026
Around Boston, there’s quiet chatter about Merck possibly shopping for smaller mRNA platform players, as they did with OncoImmune for $2 billion in 2020.